Collegium Pharmaceutical (COLL) Stock Chart & Stock Price History → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free COLL Stock Alerts $33.14 +0.71 (+2.19%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Collegium Pharmaceutical Stock Price Performance5 Day Performance-3.58%1 Month Performance-11.65%3 Month Performance-10.75%6 Month Performance+29.45%Year-To-Date Performance+7.67%1 Year Performance+53.21% Receive COLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> COLL Stock Chart for Sunday, June, 2, 2024 COLL Chart by TradingView Collegium Pharmaceutical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$32.43$33.14+2.19%$33.50$32.28566,503 shs$1.08 billion05/30/2024$33.20$32.43-2.32%$33.65$32.08877,216 shs$1.06 billion05/29/2024$34.37$33.20-3.40%$34.18$32.80417,544 shs$1.09 billion05/28/2024$34.25$34.37+0.35%$34.47$33.87352,406 shs$1.12 billion05/27/2024$34.25$34.25$34.55$33.68320,900 shs$1.12 billion05/24/2024$33.82$34.25+1.27%$34.55$33.68319,063 shs$1.12 billion Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$34.18$33.82-1.05%$34.55$33.34297,651 shs$1.11 billion05/22/2024$34.50$34.18-0.93%$34.82$34.03274,088 shs$1.12 billion05/21/2024$34.15$34.50+1.02%$34.86$34.14343,823 shs$1.13 billion05/20/2024$32.47$34.15+5.17%$34.22$32.40404,721 shs$1.12 billion05/17/2024$33.67$32.47-3.56%$33.74$32.38385,065 shs$1.06 billion05/16/2024$33.98$33.67-0.91%$34.11$33.32378,763 shs$1.10 billion05/15/2024$33.29$33.98+2.07%$34.81$33.301.17 million shs$1.11 billion05/14/2024$32.15$33.29+3.55%$33.33$31.79732,658 shs$1.09 billion05/13/2024$31.50$32.15+2.06%$33.35$31.37884,500 shs$1.05 billion05/10/2024$37.86$31.50-16.80%$34.00$30.472.25 million shs$1.03 billion05/09/2024$38.06$37.86-0.53%$38.60$37.60363,953 shs$1.24 billion05/08/2024$37.30$38.06+2.04%$38.28$37.22316,992 shs$1.24 billion05/07/2024$37.02$37.30+0.76%$37.65$37.00199,326 shs$1.22 billion05/06/2024$37.51$37.02-1.31%$37.92$36.88304,924 shs$1.21 billion05/03/2024$37.51$37.51$38.32$37.29297,795 shs$1.23 billion05/02/2024$37.78$37.51-0.71%$38.16$37.18312,815 shs$1.23 billion05/01/2024$36.93$37.78+2.30%$38.46$37.03369,821 shs$1.24 billion04/30/2024$36.71$36.93+0.60%$38.18$36.75330,948 shs$1.21 billion04/29/2024$36.42$36.71+0.80%$37.17$36.51212,112 shs$1.20 billion04/26/2024$35.84$36.42+1.62%$36.57$35.79252,821 shs$1.19 billion04/25/2024$35.48$35.84+1.01%$36.01$35.05338,007 shs$1.17 billion04/24/2024$35.94$35.48-1.28%$36.02$35.33302,816 shs$1.16 billion04/23/2024$34.74$35.94+3.45%$36.51$34.92618,658 shs$1.18 billion04/22/2024$34.84$34.74-0.29%$35.30$34.55414,728 shs$1.14 billion04/19/2024$34.77$34.84+0.20%$35.34$34.24325,319 shs$1.14 billion04/18/2024$35.45$34.77-1.92%$35.47$34.69203,938 shs$1.14 billion04/17/2024$35.40$35.45+0.14%$35.73$34.83256,530 shs$1.16 billion04/16/2024$35.14$35.40+0.74%$35.81$34.75323,773 shs$1.16 billion04/15/2024$35.71$35.14-1.60%$35.83$35.12366,302 shs$1.15 billion04/12/2024$36.39$35.71-1.87%$36.51$35.47380,381 shs$1.17 billion04/11/2024$37.99$36.39-4.21%$37.97$35.72462,878 shs$1.19 billion04/10/2024$38.79$37.99-2.06%$38.89$37.95311,406 shs$1.24 billion04/09/2024$39.42$38.79-1.60%$39.53$38.41204,177 shs$1.24 billion04/08/2024$39.99$39.42-1.43%$40.02$38.89235,209 shs$1.26 billionBiotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>>04/05/2024$39.30$39.99+1.76%$40.24$39.05384,715 shs$1.28 billion04/04/2024$39.45$39.30-0.38%$40.49$39.17366,245 shs$1.26 billion04/03/2024$38.40$39.45+2.73%$39.46$38.24261,625 shs$1.26 billion04/02/2024$38.88$38.40-1.23%$39.03$38.12335,174 shs$1.23 billion04/01/2024$38.82$38.88+0.15%$38.97$37.63351,382 shs$1.24 billion03/29/2024$38.82$38.82$40.95$38.59613,299 shs$1.24 billion03/28/2024$40.91$38.82-5.11%$40.95$38.59613,299 shs$1.24 billion03/27/2024$39.93$40.91+2.45%$40.91$39.97362,313 shs$1.31 billion03/26/2024$40.16$39.93-0.57%$40.32$39.44335,554 shs$1.28 billion03/25/2024$39.72$40.16+1.11%$40.59$39.55273,351 shs$1.28 billion03/22/2024$39.66$39.72+0.15%$39.96$39.13319,417 shs$1.27 billion03/21/2024$38.79$39.66+2.24%$39.80$38.47584,073 shs$1.27 billion03/20/2024$37.96$38.79+2.19%$38.88$37.29519,232 shs$1.24 billion03/19/2024$39.35$37.96-3.53%$39.37$37.74855,053 shs$1.21 billion03/18/2024$39.09$39.35+0.67%$39.90$38.86502,272 shs$1.26 billion03/15/2024$38.03$39.09+2.79%$39.45$37.641.99 million shs$1.25 billion03/14/2024$38.30$38.03-0.70%$38.33$37.21383,451 shs$1.22 billion03/13/2024$37.40$38.30+2.41%$38.48$37.01337,755 shs$1.22 billion03/12/2024$37.50$37.40-0.27%$37.72$36.79310,737 shs$1.20 billion03/11/2024$37.60$37.50-0.27%$37.97$36.97495,658 shs$1.20 billion03/08/2024$37.20$37.60+1.08%$38.39$37.34427,986 shs$1.20 billion03/07/2024$36.68$37.20+1.42%$37.23$36.46332,330 shs$1.19 billion03/06/2024$36.31$36.68+1.02%$36.92$35.91403,353 shs$1.17 billion03/05/2024$37.03$36.31-1.94%$37.09$35.92318,168 shs$1.16 billion03/04/2024$37.13$37.03-0.27%$37.65$36.61294,944 shs$1.18 billion03/01/2024$36.71$37.13+1.14%$37.50$36.50418,575 shs$1.19 billion Related Companies: NKTR Stock Chart INZY Stock Chart EGRX Stock Chart ALPN Stock Chart NUVL Stock Chart ALKS Stock Chart PRGO Stock Chart CRNX Stock Chart AXSM Stock Chart BHVN Stock Chart Receive COLL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COLL) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.